Trials / Unknown
UnknownNCT05892120
A Smartphone App on Medication Adherence
The Effectiveness of a Smartphone App on Medication Adherence and Psychotic Symptoms and Cognitive Functions in Patients With Schizophrenia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Detailed description
Schizophrenia is a mental disorder that causes severe functional disabilities and imposes a heavy economic burden. Poor medication adherence is one of the major causes of relapse of psychiatric symptoms in schizophrenic patients. This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | the MedAdhere app | The experimental group downloaded and used the MedAdhere app on their personal smartphones during this 8-week study |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2023-07-25
- Completion
- 2023-12-31
- First posted
- 2023-06-07
- Last updated
- 2023-06-07
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05892120. Inclusion in this directory is not an endorsement.